An integrated chinmedomics strategy for discovery of effective constituents from traditional herbal medicine

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wang, Xijun ^a   Zhang, Aihua ^a   Zhou, Xiaohang ^a   Liu, Qi ^a   Nan, Yang ^a   Guan, Yu ^a   Kong, Ling ^a   Han, Ying ^a   Sun, Hui ^a   Yan, Guangli ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BIOLOGICAL MARKER; BIOLOGICAL PRODUCT; HERBACEOUS AGENT; LIPID; SHENQUI-WAN;

ANIMAL; BLOOD; CHEMISTRY; CHINESE MEDICINE; DISEASE MODEL; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY; MALE; MEDICINAL PLANT; METABOLISM; METABOLOMICS; PATHOLOGY; PHYTOTHERAPY; PROCEDURES; RAT; WISTAR RAT; YANG DEFICIENCY;

ALDOSTERONE; ANIMALS; BIOLOGICAL PRODUCTS; BIOMARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; HUMANS; KIDNEY; LIPIDS; MALE; MEDICINE, CHINESE TRADITIONAL; METABOLOMICS; PHYTOTHERAPY; PLANTS, MEDICINAL; RATS; RATS, WISTAR; YANG DEFICIENCY;

EID: 84954183222     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18997     Document Type: Article

References (23)

1. Wang, L. et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA 105, 4826-4831(2008).
2. Wang, X. et al. Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies. Mol Cell Proteomics 12, 1226-1238 (2013).
3. Zhang, A., Sun, H. & Wang, X. Potentiating therapeutic effects by enhancing synergism based on active constituents from traditional medicine. Phytother Res 28, 526-533(2014).
4. Wang, X. J. Progress and future developing of the serum pharmacochemistry of traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi 31, 789-792 (2006).
5. Yan, G. L. et al. An effective method for determining the ingredients of Shuanghuanglian formula in blood samples using high-resolution LC-MS coupled with background subtraction and a multiple data processing approach. J Sep Sci. 36, 3191-9 (2013).
6. Zhang, A. et al. Identification and characterization of the chemical constituents of Simiao Wan by ultra high performance liquid chromatography with mass spectrometry coupled to an automated multiple data processing method. J Sep Sci. 37, 1742-7 (2014).
7. Chen, Y. et al. Pharmacokinetic profile and metabolite identification of yuanhuapine, a bioactive component in Daphne genkwa by ultra-high performance liquid chromatography coupled with tandem mass spectrometry. J Pharm Biomed Anal. 112, 60-69(2015).
8. Wang, X. et al. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J Pharm Biomed Anal. 55, 859-868(2011).
9. Wang, X., Zhang, A. & Sun, H. Future perspectives of Chinese medical formulae: chinmedomics as an effector. OMICS. 16, 414-421(2012).
10. Liu, X. et al. Pharmacological tools for the development of traditional Chinese medicine. Trends Pharmacol Sci. 34, 620-628(2013).
11. Zhao, L. et al. Metabolic Signatures of Kidney Yang Deficiency Syndrome and Protective Effects of Two Herbal Extracts in Rats Using GC/TOF MS. Evid Based Complement Alternat Med. 2013, 540957 (2013).
12. Huang, D. et al. An integrated plasma and urinary metabonomic study using UHPLC-MS: intervention effects of Epimedium koreanum on 'Kidney-Yang Deficiency syndrome' rats. J Pharm Biomed Anal. 76, 200-206(2013).
13. Lu, X. et al. Metabonomic study on 'Kidney-Yang Deficiency syndrome' and intervention effects of Rhizoma Drynariae extracts in rats using ultra performance liquid chromatography coupled with mass spectrometry. Talanta. 83, 700-708(2011).
14. Chen, M., Zhao, L. & Jia, W. Metabonomic study on the biochemical profiles of a hydrocortisone-induced animal model. J Proteome Res. 4, 2391-2396(2005).
15. Gu, Y., Chen, J. & Shen, J. Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets. J Neuroimmune Pharmacol. 9, 313-339(2014).
16. Zhang, A. et al. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach. Complement Ther Med. 20, 93-99(2012).
17. Zhang, A. et al. An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen-Hao-Tang based on its active constituents. Fitoterapia. 82, 1160-1168(2011).
18. Zhang, A. et al. Metabolomics: towards understanding traditional Chinese medicine. Planta Med. 76, 2026-2035 (2010).
19. Zhang, A. H. et al. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets. Anal Chem. 85, 7606-7612(2013).
20. Wang, X. et al. Pattern recognition approaches and computational systems tools for ultra performance liquid chromatography-mass spectrometry-based comprehensive metabolomic profiling and pathways analysis of biological data sets. Anal Chem. 84, 428-439(2012).
21. Chen, Y. et al. A metabolomic study of rats with Doxorubicin-induced cardiomyopathy and shengmai injection treatment. PLoS One. 10, e0125209(2015).
22. Sun, H., Zhang, A. & Wang, X. Potential role of metabolomic approaches for Chinese medicine syndromes and herbal medicine. Phytother Res. 26, 1466-1471(2012).
23. Zhang, A. H. et al. Chinmedomics: a new strategy for research of traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi. 40, 569-576(2015).